Home » Topics » BioWorld Science

BioWorld Science
RSS

AbbVie presents key events from fourth quarter 2017

Jan. 31, 2018

First Wave Bio cleared to begin clinical testing of lead product candidate

Jan. 31, 2018

Otsuka awarded grant to advance OPC-167832/delamanid combination for tuberculosis

Jan. 31, 2018

Phase I data presented for JCAR-017 in B-NHL

Jan. 30, 2018

Johnson & Johnson reviews pipeline progress of fourth quarter 2017

Jan. 30, 2018

FDA accepts revefenacin NDA

Jan. 30, 2018

ProMetic Life Sciences finalizes design of phase III study of PBI-4050 in IPF

Jan. 30, 2018

Ibentrus identifies new fusion proteins for cancer

Jan. 30, 2018

Duke University patents APC-containing vaccines for cancer

Jan. 30, 2018

Almac Discovery discloses new Wee1 inhibitors

Jan. 30, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...